Decoding intrathecal immunoglobulins and B cells in the CNS: their synthesis, function, and regulation

References

• Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337–341. doi:10.1038/nature14432.
   PubMed Web of Science ®Google Scholar
• Cserr HF, Harling-Berg CJ, Knopf PM. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. 1992;2(4):269–276. doi:10.1111/j.1750-3639.1992.tb00703.x.
   PubMed Web of Science ®Google Scholar
• Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991–999. doi:10.1084/jem.20142290.
   PubMed Web of Science ®Google Scholar
• Prinz M, Priller J. The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci. 2017;20(2):136–144. doi:10.1038/nn.4475.
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841–845. doi:10.1126/science.1194637.
   PubMed Web of Science ®Google Scholar
• Negi N, Das BK. CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ. Int Rev Immunol. 2018;37(1):57–68. doi:10.1080/08830185.2017.1357719.
   PubMed Web of Science ®Google Scholar
• Kivisakk P, Imitola J, Rasmussen S, et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol. 2009;65:457–469. doi:10.1002/ana.21379.
   PubMed Web of Science ®Google Scholar
• Greter M, Lelios I, Croxford AL. Microglia versus myeloid cell nomenclature during brain inflammation. Front Immunol. 2015;6:249. doi:10.3389/fimmu.2015.00249.
   PubMed Web of Science ®Google Scholar
• Bechmann I, Kwidzinski E, Kovac AD, et al. Turnover of rat brain perivascular cells. Exp Neurol. 2001;168(2):242–249. doi:10.1006/exnr.2000.7618.
   PubMed Web of Science ®Google Scholar
• Mrdjen D, Pavlovic A, Hartmann FJ, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48(3):599. doi:10.1016/j.immuni.2018.02.014.
   PubMed Web of Science ®Google Scholar
• Steinbach K, Vincenti I, Kreutzfeldt M, et al. Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection. J Exp Med. 2016;213(8):1571–1587. doi:10.1084/jem.20151916.
   PubMed Web of Science ®Google Scholar
• Kivisakk P, Mahad DJ, Callahan MK, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA. 2003;100:8389–8394. doi:10.1073/pnas.1433000100.
   PubMed Web of Science ®Google Scholar
• Cayrol R, Wosik K, Berard JL, et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol. 2008;9(2):137–145. doi:10.1038/ni1551.
   PubMed Web of Science ®Google Scholar
• Lehmann-Horn K, Sagan SA, Bernard CC, et al. B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity. Ann Neurol. 2015;77(5):902–908. doi:10.1002/ana.24387.
   PubMed Web of Science ®Google Scholar
• Alter A, Duddy M, Hebert S, et al. Determinants of human B cell migration across brain endothelial cells. J Immunol. 2003;170(9):4497–4505. doi:10.4049/jimmunol.170.9.4497.
   PubMed Web of Science ®Google Scholar
• Krumbholz M, Theil D, Cepok S, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006;129(1):200–211. doi:10.1093/brain/awh680.
   PubMedGoogle Scholar
• Allen CD, Ansel KM, Low C, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004;5(9):943–952. doi:10.1038/ni1100.
   PubMed Web of Science ®Google Scholar
• Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA. 2004;101(30):11064–11069. doi:10.1073/pnas.0402455101.
   PubMed Web of Science ®Google Scholar
• Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 2004;20(4):441–453. doi:10.1016/S1074-7613(04)00079-2.
   PubMed Web of Science ®Google Scholar
• Thangarajh M, Masterman T, Hillert J, et al. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand J Immunol. 2007;65(1):92–98. doi:10.1111/j.1365-3083.2006.01867.x.
   PubMed Web of Science ®Google Scholar
• Seyler TM, Park YW, Takemura S, et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest. 2005;115(11):3083–3092. doi:10.1172/JCI25265.
   PubMed Web of Science ®Google Scholar
• Stohl W, Metyas S, Tan SM, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003;48(12):3475–3486. doi:10.1002/art.11354.
   PubMed Web of Science ®Google Scholar
• Khairnar V, Duhan V, Maney SK, et al. CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. Nat Commun. 2015;6(1):6217. doi:10.1038/ncomms7217.
   PubMedGoogle Scholar
• Rovituso DM, Scheffler L, Wunsch M, et al. CEACAM1 mediates B cell aggregation in central nervous system autoimmunity. Sci Rep. 2016;6(1):29847. doi:10.1038/srep29847.
   PubMedGoogle Scholar
• Banks WA, Terrell B, Farr SA, et al. Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease. Peptides. 2002;23(12):2223–2226. doi:10.1016/S0196-9781(02)00261-9.
   PubMed Web of Science ®Google Scholar
• Puthenparampil M, Federle L, Miante S, et al. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset. J Neuroinflammation. 2017;14(1):11. doi:10.1186/s12974-016-0785-2.
   PubMedGoogle Scholar
• Stauch C, Reiber H, Rauchenzauner M, et al. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis. Mult Scler. 2011;17(3):327–334. doi:10.1177/1352458510388543.
   PubMed Web of Science ®Google Scholar
• Bonnan M. Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments. Mult Scler Int. 2015;2015:296184. doi:10.1155/2015/296184.
   PubMedGoogle Scholar
• DiSano KD, Royce DB, Gilli F, et al. Central nervous system inflammatory aggregates in the Theiler's virus model of progressive multiple sclerosis. Front Immunol. 2019;10:1821.
   PubMed Web of Science ®Google Scholar
• Tau GZ, Peterson BS. Normal development of brain circuits. Neuropsychopharmacol.. 2010;35(1):147–168. doi:10.1038/npp.2009.115.
   PubMed Web of Science ®Google Scholar
• Domingues HS, Portugal CC, Socodato R, et al. Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair. Front Cell Dev Biol. 2016;4:71. doi:10.3389/fcell.2016.00071.
   PubMed Web of Science ®Google Scholar
• Kiray H, Lindsay SL, Hosseinzadeh S, et al. The multifaceted role of astrocytes in regulating myelination. Exp Neurol. 2016;283:541–549. doi:10.1016/j.expneurol.2016.03.009.
   PubMed Web of Science ®Google Scholar
• Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol. 2003;24(6):343–349.
   PubMed Web of Science ®Google Scholar
• Fereidan-Esfahani M, Nayfeh T, Warrington A, et al. IgM natural autoantibodies in physiology and the treatment of disease. Methods Mol Biol. 2019;1904:53–81. doi:10.1007/978-1-4939-8958-4_3.
   PubMedGoogle Scholar
• Xu X, Ng SM, Hassouna E, et al. Human-derived natural antibodies: biomarkers and potential therapeutics. Future Neurol. 2015;10(1):25–39. doi:10.2217/fnl.14.62.
   PubMed Web of Science ®Google Scholar
• Elkon K, Casali P. Nature and functions of autoantibodies. Nat Rev Rheumatol. 2008;4(9):491–498. doi:10.1038/ncprheum0895.
   Google Scholar
• Baumgarth N. B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production. Front Immunol. 2016;7:324. doi:10.3389/fimmu.2016.00324.
   PubMed Web of Science ®Google Scholar
• Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11(1):34–46. doi:10.1038/nri2901.
   PubMed Web of Science ®Google Scholar
• Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today. 1999;20(7):312–316. doi:10.1016/S0167-5699(99)01476-0.
   PubMedGoogle Scholar
• Marie-Cardine A, Divay F, Dutot I, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008;127(1):14–25. doi:10.1016/j.clim.2007.11.013.
   PubMed Web of Science ®Google Scholar
• Tanabe S, Yamashita T. B-1a lymphocytes promote oligodendrogenesis during brain development. Nat Neurosci. 2018;21(4):506–516. doi:10.1038/s41593-018-0106-4.
   PubMed Web of Science ®Google Scholar
• Jaseb K, Purrahman D, Shahrabi S, et al. Prognostic significance of aberrant CD5 expression in B-cell leukemia. Oncol Rev. 2019;13(1):400. doi:10.4081/oncol.2019.400.
   PubMed Web of Science ®Google Scholar
• Lobo PI. Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease. Front Immunol. 2016;7:198. doi:10.3389/fimmu.2016.00198.
   PubMed Web of Science ®Google Scholar
• Bagnara D, Squillario M, Kipling D, et al. A reassessment of IgM memory subsets in humans. J Immunol. 2015;195(8):3716–3724. doi:10.4049/jimmunol.1500753.
   PubMed Web of Science ®Google Scholar
• Avrameas S, Alexopoulos H, Moutsopoulos HM. Natural autoantibodies: an undersugn hero of the immune system and autoimmune disorders-a point of view. Front Immunol. 2018;9:1320. doi:10.3389/fimmu.2018.01320.
   PubMed Web of Science ®Google Scholar
• Swanson PA, 2nd, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44–54. doi:10.1016/j.coviro.2014.12.009.
   PubMed Web of Science ®Google Scholar
• Louveau A, Plog BA, Antila S, et al. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest. 2017;127(9):3210–3219. doi:10.1172/JCI90603.
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18(2):123–131. doi:10.1038/ni.3666.
   PubMed Web of Science ®Google Scholar
• Stern JN, Yaari G, Vander Heiden JA, et al. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med. 2014;6(248):248ra107. doi:10.1126/scitranslmed.3008879.
   PubMed Web of Science ®Google Scholar
• Tourtellotte WW, Potvin AR, Fleming JO, et al. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology. 1980;30(3):240–244. doi:10.1212/WNL.30.3.240.
   PubMed Web of Science ®Google Scholar
• Mitsdoerffer M, Peters A. Tertiary lymphoid organs in central nervous system autoimmunity. Front Immunol. 2016;7:451. doi:10.3389/fimmu.2016.00451.
   PubMed Web of Science ®Google Scholar
• Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol. 2006;6(3):205–217. doi:10.1038/nri1786.
   PubMed Web of Science ®Google Scholar
• Li R, Bar-Or A. The multiple roles of B cells in multiple sclerosis and their implications in multiple sclerosis therapies. Cold Spring Harb Perspect Med. 2019;9(4):a029108. doi:10.1101/cshperspect.a029108.
   PubMed Web of Science ®Google Scholar
• LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570–1580. doi:10.1182/blood-2008-02-078071.
   PubMed Web of Science ®Google Scholar
• Li R, Patterson KR, Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat Immunol. 2018;19(7):696–707. doi:10.1038/s41590-018-0135-x.
   PubMed Web of Science ®Google Scholar
• Palanichamy A, Apeltsin L, Kuo TC, et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med. 2014;6(248):248ra106. doi:10.1126/scitranslmed.3008930.
   PubMed Web of Science ®Google Scholar
• Cid C, Regidor I, Alcazar A. Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission. J Neuroimmunol. 2007;184(1-2):223–226. doi:10.1016/j.jneuroim.2006.11.001.
   PubMed Web of Science ®Google Scholar
• Hohlfeld R, Dornmair K, Meinl E, et al. The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. Lancet Neurol. 2016;15(3):317–331. doi:10.1016/S1474-4422(15)00313-0.
   PubMed Web of Science ®Google Scholar
• Arneth BM. Impact of B cells to the pathophysiology of multiple sclerosis. J Neuroinflammation. 2019;16(1):128. doi:10.1186/s12974-019-1517-1.
   PubMed Web of Science ®Google Scholar
• Probstel AK, Sanderson NS, Derfuss T. B cells and autoantibodies in multiple sclerosis. Int J Mol Sci. 2015;16:16576–16592. doi:10.3390/ijms160716576.
   PubMed Web of Science ®Google Scholar
• Wanleenuwat P, Iwanowski P. Role of B cells and antibodies in multiple sclerosis. Mult Scler Relat Disord. 2019;36:101416. doi:10.1016/j.msard.2019.101416.
   PubMedGoogle Scholar
• von Budingen HC, Kuo TC, Sirota M, et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest. 2012;122:4533–4543. doi:10.1172/JCI63842.
   PubMed Web of Science ®Google Scholar
• Dhaeze T, Peelen E, Hombrouck A, et al. Circulating follicular regulatory T cells are defective in multiple sclerosis. J Immunol. 2015;195(3):832–840. doi:10.4049/jimmunol.1500759.
   PubMed Web of Science ®Google Scholar
• Dombrowski Y, O'Hagan T, Dittmer M, et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nat Neurosci. 2017;20(5):674–680. doi:10.1038/nn.4528.
   PubMed Web of Science ®Google Scholar
• Knier B, Hiltensperger M, Sie C, et al. Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity. Nat Immunol. 2018;19(12):1341–1351. doi:10.1038/s41590-018-0237-5.
   PubMed Web of Science ®Google Scholar
• Knippenberg S, Peelen E, Smolders J, et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J Neuroimmunol. 2011;239(1-2):80–86. doi:10.1016/j.jneuroim.2011.08.019.
   PubMed Web of Science ®Google Scholar
• Pfuhl C, Grittner U, Giess RM, et al. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis. Neurology. 2019; 15:620–621.
   PubMedGoogle Scholar
• Gasperi C, Salmen A, Antony G, et al. Association of intrathecal immunoglobulin G synthesis with disability worsening in multiple sclerosis. JAMA Neurol. 2019;76(7):841–849. doi:10.1001/jamaneurol.2019.0905.
   PubMed Web of Science ®Google Scholar
• Wright BR, Warrington AE, Edberg DD, et al. Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. Arch Neurol. 2009;66(12):1456–1459. doi:10.1001/archneurol.2009.262.
   PubMedGoogle Scholar
• Gholamzad M, Ebtekar M, Ardestani MS, et al. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflamm Res. 2019;68(1):25–38. doi:10.1007/s00011-018-1185-0.
   PubMed Web of Science ®Google Scholar
• Nguyen AL, Gresle M, Marshall T, et al. Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. Br J Pharmacol. 2017;174(13):1895–1907. doi:10.1111/bph.13780.
   PubMed Web of Science ®Google Scholar
• Juanatey A, Blanco-Garcia L, Tellez N. Ocrelizumab: its efficacy and safety in multiple sclerosis. Rev Neurol. 2018;66(12):423–433.
   PubMed Web of Science ®Google Scholar
• Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008;358(7):676–688. doi:10.1056/NEJMoa0706383.
   PubMed Web of Science ®Google Scholar
• Sorensen PS, Lisby S, Grove R, et al. Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study. Neurology. 2014;82(7):573–581. doi:10.1212/WNL.0000000000000125.
   PubMed Web of Science ®Google Scholar
• Scolding NJ, Pasquini M, Reingold SC, et al. Cell-based therapeutic strategies for multiple sclerosis. Brain. 2017;140(11):2776–2796. doi:10.1093/brain/awx154.
   PubMed Web of Science ®Google Scholar
• Kuperstein I, Broersen K, Benilova I, et al. Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 2010;29(19):3408–3420. doi:10.1038/emboj.2010.211.
   PubMed Web of Science ®Google Scholar
• Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer's disease. J Cell Biol. 2018;217(2):459–472. doi:10.1083/jcb.201709069.
   PubMed Web of Science ®Google Scholar
• Marsh SE, Abud EM, Lakatos A, et al. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci USA. 2016;113(9):E1316-25. doi:10.1073/pnas.1525466113.
   PubMed Web of Science ®Google Scholar
• Dodel R, Balakrishnan K, Keyvani K, et al. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease. J Neurosci. 2011;31(15):5847–5854. doi:10.1523/JNEUROSCI.4401-10.2011.
   PubMed Web of Science ®Google Scholar
• Klyubin I, Cullen WK, Hu NW, et al. Alzheimer's disease Abeta assemblies mediating rapid disruption of synaptic plasticity and memory. Mol Brain. 2012;5(1):25. doi:10.1186/1756-6606-5-25.
   PubMedGoogle Scholar
• Sollvander S, Ekholm-Pettersson F, Brundin RM, et al. Increased number of plasma B cells producing autoantibodies against Abeta42 protofibrils in Alzheimer's disease. J Alzheimers Dis. 2015;48:63–72. doi:10.3233/JAD-150236.
   PubMed Web of Science ®Google Scholar
• Relkin NR, Thomas RG, Rissman RA, et al. A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology. 2017;88(18):1768–1775. doi:10.1212/WNL.0000000000003904.
   PubMed Web of Science ®Google Scholar
• Xu L, Pu J. Alpha-synuclein in Parkinson's disease: from pathogenetic dysfunction to potential clinical application. Parkinsons Dis. 2016;2016:1720621. doi:10.1155/2016/1720621.
   PubMed Web of Science ®Google Scholar
• Shalash A, Salama M, Makar M, et al. Elevated serum alpha-synuclein autoantibodies in patients with Parkinson's disease relative to Alzheimer's disease and controls. Front Neurol. 2017;8:720.
   PubMed Web of Science ®Google Scholar
• Kannarkat GT, Boss JM, Tansey MG. The role of innate and adaptive immunity in Parkinson's disease. J Parkinsons Dis. 2013;3(4):493–514. doi:10.3233/JPD-130250.
   PubMedGoogle Scholar
• Brudek T, Winge K, Folke J, et al. Autoimmune antibody decline in Parkinson's disease and multiple system atrophy; a step towards immunotherapeutic strategies. Mol Neurodegener. 2017;12(1):44 doi:10.1186/s13024-017-0187-7.
   PubMedGoogle Scholar
• Masliah E, Rockenstein E, Adame A, et al. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron. 2005;46(6):857–868. doi:10.1016/j.neuron.2005.05.010.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Goodman I, Safirstein B, et al. Safety and tolerability of multiple ascending doses of PRX002/RG7935, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson disease: a randomized clinical trial. JAMA Neurol. 2018;75(10):1206–1214. doi:10.1001/jamaneurol.2018.1487.
   PubMed Web of Science ®Google Scholar
• Li X, Koudstaal W, Fletcher L, et al. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol. 2019;137(5):825–836. doi:10.1007/s00401-019-01974-5.
   PubMed Web of Science ®Google Scholar